Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 2,777,900 | 2,591,600 | 2,555,000 | 2,640,650 | 2,511,446 |
| Cost of Goods | 310,000 | 286,100 | 312,400 | 297,229 | 302,639 |
| Gross Profit | 2,467,900 | 2,305,500 | 2,242,600 | 2,343,422 | 2,208,807 |
| Operating Expenses | 1,096,000 | 1,072,500 | 1,125,000 | 1,183,802 | 1,056,868 |
| Operating Income | 1,371,800 | 1,233,100 | 1,117,900 | 1,159,749 | 1,152,578 |
| Other Income | -22,200 | -15,800 | -15,800 | -8,938 | -21,684 |
| Pre-tax Income | 1,349,600 | 1,217,300 | 1,102,100 | 1,150,811 | 1,130,894 |
| Income Tax | 330,100 | 292,500 | 281,900 | 268,191 | 274,774 |
| Net Income Continuous | 1,019,500 | 924,800 | 820,200 | 882,620 | 856,120 |
| Minority Interests | 53,900 | -2,500 | -2,400 | -860 | -738 |
| Net Income | $965,600 | $927,300 | $822,600 | $883,480 | $856,858 |
| EPS Basic Total Ops | 4.16 | 3.94 | 3.50 | 3.74 | 3.63 |
| EPS Basic Continuous Ops | 4.39 | 3.93 | 3.49 | 3.74 | 3.62 |
| EPS Diluted Total Ops | 4.15 | 3.93 | 3.49 | 3.72 | 3.62 |
| EPS Diluted Continuous Ops | 4.38 | 3.92 | 3.48 | 3.73 | 3.61 |
| EBITDA(a) | $1,523,500 | $1,377,700 | $1,265,900 | $1,317,441 | $1,327,984 |